MOTS-c: Mitochondrial-Derived Peptide in Metabolic Regulation Research¶
Executive Summary¶
MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome, specifically derived from the 12S rRNA gene (MT-RNR2). Discovered in 2015 by Lee, Cohen, and colleagues at the University of Southern California and published in Cell Metabolism, MOTS-c represents a paradigm-shifting discovery in cell biology: a peptide translated within mitochondria that functions as a systemic signaling molecule, communicating mitochondrial status to the nucleus and to distant tissues to coordinate metabolic adaptation (Lee et al., 2015).
MOTS-c belongs to a growing family of mitochondrial-derived peptides (MDPs) that challenge the traditional view of mitochondria as exclusively bioenergetic organelles, revealing their additional role as signaling hubs that release bioactive peptides to regulate cellular and organismal physiology. The peptide's primary mechanism involves modulation of the folate-methionine cycle (one-carbon metabolism), leading to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a well-characterized endogenous activator of AMP-activated protein kinase (AMPK) — the master energy sensor of the cell. Through AMPK activation, MOTS-c triggers a coordinated program of metabolic adaptation that closely mimics the response to endurance exercise: enhanced glucose uptake, increased fatty acid oxidation, and mitochondrial biogenesis.
Research interest in MOTS-c has expanded rapidly since its discovery. Studies have demonstrated that MOTS-c treatment can prevent age-dependent and high-fat-diet-induced insulin resistance, reduce adiposity, and improve exercise capacity in aged mice (Kim et al., 2019). Circulating MOTS-c levels increase with exercise and decline with age, positioning the peptide as both a mediator of exercise benefits and a potential biomarker of metabolic health. Beyond metabolic regulation, emerging research has identified roles for MOTS-c in bone homeostasis, cardiovascular protection, neuroprotection, and cellular stress response through interaction with the integrated stress response (ISR) pathway.
MOTS-c is exclusively a research compound and has not been evaluated in human clinical trials. It is not approved for clinical use by the FDA, EMA, or any other regulatory agency. High-purity MOTS-c with comprehensive analytical documentation is available from RPL Peptide, with detailed molecular characterization data at the RPL Peptide Data Center.
Background¶
Discovery History¶
The discovery of MOTS-c emerged from a systematic bioinformatic search for small open reading frames (sORFs) within the mitochondrial genome capable of encoding bioactive peptides. The mitochondrial genome — a circular DNA molecule of approximately 16.6 kb encoding 13 protein subunits of the oxidative phosphorylation system, 22 tRNAs, and 2 rRNAs — had traditionally been viewed as encoding a fixed and well-characterized set of gene products. However, advances in ribosome profiling and mass spectrometry-based peptidomics in the 2010s revealed that the mitochondrial genome harbors previously unrecognized sORFs encoding short peptides with biological functions extending beyond oxidative phosphorylation.
Lee and colleagues (2015) systematically scanned the mitochondrial 12S rRNA gene (MT-RNR2) for sORFs and identified several candidate peptides, including one 16-amino-acid sequence designated MOTS-c (mitochondrial open reading frame of the 12S rRNA-c). The peptide was shown to be translated within mitochondria using the mitochondrial genetic code (which differs from the nuclear genetic code), processed, and released into the cytoplasm, from where it could be secreted into the circulation.
The discovery that a mitochondrial-encoded peptide could function as a systemic signaling molecule was transformative. It established the concept of retrograde mitochondrial signaling through peptide mediators — a new layer of inter-organelle and inter-tissue communication in which mitochondria not only respond to cellular signals but actively generate them. This finding positioned MOTS-c alongside Humanin (discovered in 2001) and the SHLP peptides (small humanin-like peptides, discovered in 2013) as members of a growing family of mitochondrial-derived peptides with diverse biological functions.
Research Context: Mitonuclear Communication¶
MOTS-c must be understood within the broader framework of mitonuclear communication — the bidirectional signaling between mitochondria and the nucleus that coordinates cellular metabolism, stress responses, and adaptation. The classical paradigm emphasized anterograde signaling (nucleus → mitochondria): nuclear-encoded transcription factors (NRF-1, NRF-2, PGC-1α) regulate the expression of mitochondrial genes, ensuring that mitochondrial biogenesis and function are matched to cellular energy demands (Quiros et al., 2016).
The discovery of MDPs revealed the complementary retrograde pathway (mitochondria → nucleus): mitochondrial-derived peptides are translated within the organelle, released in response to metabolic stress, and translocate to the nucleus to regulate gene expression. MOTS-c exemplifies this paradigm. Under conditions of metabolic stress — glucose deprivation, serum starvation, oxidative stress — MOTS-c translocates from mitochondria to the nucleus, where it influences the expression of genes involved in metabolism, stress resistance, and cellular adaptation (Kim et al., 2022).
The identification of MOTS-c and other MDPs has profound implications for understanding the integration of cellular metabolism. Mitochondria, once viewed primarily as ATP-producing organelles, are now recognized as signaling platforms that release peptide hormones to coordinate systemic metabolic responses — a conceptual transformation that parallels the earlier recognition of adipose tissue and skeletal muscle as endocrine organs.
Core Science¶
Mechanism of Action: The MOTS-c → AICAR → AMPK Cascade¶
The canonical mechanism of MOTS-c action is a multi-step signaling cascade that links mitochondrial peptide production to systemic metabolic regulation:
1. The Folate-Methionine Cycle Connection¶
Upon cellular uptake, MOTS-c directly interacts with and modulates key enzymes in the folate-methionine cycle (one-carbon metabolism), including: - Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2): A mitochondrial enzyme that catalyzes the conversion of 5,10-methylenetetrahydrofolate to 10-formyltetrahydrofolate - Methionine adenosyltransferase (MAT): Catalyzes the synthesis of S-adenosylmethionine (SAM), the universal methyl donor
By modulating flux through these enzymes, MOTS-c influences the balance of one-carbon metabolites and, critically, the cellular levels of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). AICAR is an intermediate in de novo purine biosynthesis that also functions as an endogenous allosteric activator of AMPK (Lee et al., 2015).
2. AICAR Accumulation and AMPK Activation¶
The MOTS-c-induced increase in AICAR levels leads to activation of AMP-activated protein kinase (AMPK), the master cellular energy sensor. AMPK is a heterotrimeric serine/threonine kinase composed of a catalytic α-subunit and regulatory β- and γ-subunits. The γ-subunit contains four cystathionine β-synthase (CBS) domains that bind adenine nucleotides; binding of AMP or AICAR (as its monophosphate derivative ZMP) to the γ-subunit triggers a conformational change that promotes phosphorylation of the α-subunit at Thr172 by upstream kinases (LKB1, CaMKKβ) and inhibits dephosphorylation by protein phosphatases (Cantó & Auwerx, 2010).
The cascade — MOTS-c → folate cycle modulation → AICAR/ZMP accumulation → AMPK activation — provides a direct mechanistic link between a mitochondrial-encoded peptide and the master energy sensor of the cell.
3. AMPK Downstream Targets and Metabolic Adaptation¶
Once activated, AMPK phosphorylates a broad array of downstream targets to orchestrate a coordinated metabolic shift toward catabolism and energy production:
- TBC1D1 (TBC1 domain family member 1): AMPK phosphorylation of TBC1D1 promotes GLUT4 translocation to the plasma membrane, enhancing glucose uptake in skeletal muscle. This effect is central to MOTS-c's insulin-sensitizing action.
- Acetyl-CoA carboxylase (ACC): AMPK phosphorylation inhibits ACC, reducing malonyl-CoA levels. Since malonyl-CoA is a potent inhibitor of carnitine palmitoyltransferase 1 (CPT1) — the rate-limiting enzyme for mitochondrial fatty acid uptake — ACC inhibition de-represses fatty acid oxidation.
- PGC-1α (peroxisome proliferator-activated receptor γ coactivator 1α): AMPK directly phosphorylates and activates PGC-1α, the master regulator of mitochondrial biogenesis. PGC-1α co-activates transcription factors (NRF-1, NRF-2, ERRα, PPARα) that drive the expression of nuclear-encoded mitochondrial genes, increasing mitochondrial mass and oxidative capacity.
- mTORC1 (mechanistic target of rapamycin complex 1): AMPK inhibits mTORC1 signaling through phosphorylation of TSC2 and Raptor, reducing anabolic processes (protein synthesis, cell growth) that are energetically expensive and redirecting cellular resources toward catabolic energy production.
The net effect of this AMPK-dependent program is a metabolic state that closely resembles the response to endurance exercise: enhanced glucose uptake independent of insulin, increased fatty acid oxidation, mitochondrial biogenesis, and improved insulin sensitivity. This exercise-mimetic property is the hallmark of MOTS-c biology and accounts for its effects on metabolic homeostasis in preclinical models.
Mitonuclear Translocation and Gene Regulation¶
Beyond its systemic metabolic effects, MOTS-c functions as an intracellular signaling molecule that mediates retrograde communication from mitochondria to the nucleus. Under basal conditions, MOTS-c is predominantly localized to mitochondria. Under conditions of metabolic stress — glucose deprivation, oxidative stress, mitochondrial dysfunction — MOTS-c translocates to the nucleus (Kim et al., 2022).
Nuclear-localized MOTS-c has been shown to regulate gene expression through interactions with transcription factors and chromatin-modifying complexes. Transcriptomic analyses have identified changes in the expression of genes involved in: - Fatty acid oxidation (CPT1B, ACADM, HADHA) - Glucose metabolism (SLC2A4/GLUT4, HK2, PFKFB3) - Mitochondrial function (TFAM, NRF1, PGC-1α) - Cellular stress response (ATF4, CHOP/DDIT3, HSPA5/BiP) - Inflammation (NF-κB target genes)
The nuclear translocation of MOTS-c represents a direct physical link between mitochondrial status and nuclear gene expression — a mechanism for communicating mitochondrial stress or metabolic state to the transcriptional machinery that governs cellular adaptation.
Integrated Stress Response (ISR) Connection¶
Recent research has identified MOTS-c as a regulator of the integrated stress response (ISR), a conserved eukaryotic signaling network that coordinates cellular adaptation to diverse stressors. The ISR is centered on phosphorylation of eIF2α (eukaryotic initiation factor 2α) by stress-sensing kinases (GCN2, PERK, PKR, HRI), which globally attenuates protein synthesis while selectively enhancing translation of stress-responsive transcription factors including ATF4 (Kim et al., 2022).
MOTS-c has been shown to interact with components of the ISR pathway, potentially functioning as a mitochondrial stress signal that primes or amplifies the ISR response. This connection between mitochondrial-derived peptide signaling and the ISR represents an emerging frontier in understanding how cells integrate information about mitochondrial status with global stress adaptation programs.
Exercise Mimetic Properties¶
The classification of MOTS-c as an exercise mimetic is supported by multiple lines of evidence:
- Administration of MOTS-c to sedentary mice reproduces key metabolic effects of exercise training, including enhanced glucose tolerance, increased fatty acid oxidation, and improved exercise endurance
- MOTS-c activates the same AMPK→PGC-1α→mitochondrial biogenesis pathway that mediates the metabolic adaptations to endurance exercise
- Circulating MOTS-c levels increase following acute exercise in both mice and humans, suggesting the peptide is a physiological mediator of exercise benefits
- MOTS-c and exercise produce overlapping gene expression signatures in skeletal muscle, particularly in pathways related to oxidative metabolism and mitochondrial function
The discovery that a mitochondrial-encoded peptide can endogenously reproduce exercise-like metabolic effects has significant implications for understanding how physical activity improves metabolic health and for developing strategies to mimic exercise benefits in populations unable to exercise.
Structure-Activity Relationships¶
| Structural Element | Functional Role |
|---|---|
| Met¹ (N-terminus) | Initiator methionine; potential for N-terminal modifications affecting stability and activity |
| Arg² | Positively charged residue; potential role in membrane interaction or target binding |
| Trp³, Tyr⁷, Tyr¹¹, Phe⁹, Phe¹⁰ | Aromatic residues; potential for membrane interaction and receptor binding through hydrophobic and π-stacking interactions |
| Gln⁴, Glu⁵ | Polar residues; contribute to solubility and may participate in hydrogen bonding with targets |
| Pro¹² | Introduces conformational constraint; may influence secondary structure |
| Arg¹³, Lys¹⁴, Arg¹⁶ | Basic C-terminal cluster: RKR motif; potential nuclear localization signal |
| Leu¹⁵ | Hydrophobic residue; contributes to potential amphipathic helical character |
| Overall amphipathic character | Predicted amphipathic α-helical N-terminal region; may facilitate membrane interaction and receptor binding |
NMR structural studies indicate that MOTS-c adopts a partially helical conformation in solution, with the N-terminal region (residues 1–9) showing α-helical propensity and the C-terminal region (residues 10–16) being more flexible. The C-terminal RKR motif resembles a classical nuclear localization signal (NLS) and may contribute to the peptide's nuclear translocation under stress conditions.
Pharmacological Properties¶
| Property | Value / Description |
|---|---|
| Molecular weight | ~2,174 Da |
| Encoding gene | MT-RNR2 (mitochondrial 12S rRNA) |
| Genetic code | Mitochondrial genetic code (differs from nuclear code at several codons) |
| Translation site | Mitochondrial ribosomes (mitoribosomes) |
| Cellular localization | Mitochondria (basal); nucleus (stress conditions); extracellular (secreted) |
| Circulating levels | Detectable in human plasma; increase with exercise; decline with age |
| Plasma half-life | Not fully characterized; estimated 30–60 minutes (rodent models) |
| Route of administration | Intraperitoneal (mouse models); subcutaneous (preclinical research) |
| Solubility | Water-soluble |
| Lyophilized stability | Stable at −20°C for >24 months |
| Tissue distribution | Skeletal muscle, liver, adipose tissue, brain, heart, bone |
Preclinical Evidence¶
Metabolic Regulation: - MOTS-c treatment (5–15 mg/kg/day, IP) for 2–4 weeks in high-fat-diet-fed mice prevented weight gain, improved glucose tolerance, and enhanced insulin sensitivity compared to vehicle-treated controls - In aged mice (22–24 months), MOTS-c treatment improved glucose homeostasis, increased exercise endurance (treadmill running time), and reduced adiposity (Kim et al., 2019) - MOTS-c enhanced glucose uptake in L6 myotubes through AMPK-dependent GLUT4 translocation, with effects comparable to insulin stimulation - MOTS-c treatment reversed age-related decline in skeletal muscle mitochondrial function, increasing Complex I and Complex IV activities
Exercise Physiology: - Circulating MOTS-c levels increased significantly (1.5–2-fold) following acute endurance exercise in both mice and human subjects - MOTS-c administration improved running endurance in aged mice to levels approaching those of young sedentary mice - MOTS-c and exercise training produced overlapping effects on skeletal muscle gene expression, particularly in oxidative metabolism pathways
Bone Metabolism: - Emerging evidence suggests MOTS-c promotes osteoblast differentiation and mineralization in vitro - In ovariectomized mouse models of osteoporosis, MOTS-c treatment attenuated bone loss and improved bone mineral density parameters - MOTS-c has been shown to regulate the RANKL/OPG ratio, a key determinant of bone remodeling balance
Cardiovascular Protection: - MOTS-c treatment reduced infarct size and improved cardiac function in rodent models of myocardial ischemia-reperfusion injury - In endothelial cells, MOTS-c protects against oxidative stress-induced dysfunction, reducing ROS production and improving nitric oxide bioavailability - MOTS-c has been reported to attenuate angiotensin II-induced hypertension and vascular remodeling in mouse models
Neuroprotection: - MOTS-c has been detected in brain tissue and cerebrospinal fluid - In models of neuronal oxidative stress, MOTS-c preserved mitochondrial membrane potential and reduced markers of apoptosis - Preliminary studies suggest potential protective effects in models of neurodegeneration, though this area remains early-stage
Research Evidence¶
| Finding | Data | Source |
|---|---|---|
| MOTS-c discovery: mitochondrial-encoded metabolic regulator | 16-aa peptide from 12S rRNA; regulates insulin sensitivity via AMPK | Lee et al., Cell Metab, 2015 |
| MOTS-c activates AMPK through AICAR pathway | Modulates folate-methionine cycle; increases AICAR/ZMP → AMPK activation | Lee et al., Cell Metab, 2015 |
| MOTS-c prevents age-related insulin resistance | Improved glucose tolerance; enhanced insulin sensitivity in aged mice (22–24 mo) | Kim et al., Nat Commun, 2019 |
| MOTS-c improves exercise capacity in aged mice | Running endurance improved 2-fold; mitochondrial function restored | Kim et al., Nat Commun, 2019 |
| Exercise increases circulating MOTS-c levels | 1.5–2-fold increase post-exercise in mice and humans | Zeng et al., Cell Rep, 2018 |
| MOTS-c nuclear translocation under metabolic stress | Mitochondria → nucleus; regulates gene expression programs | Kim et al., Cell Metab, 2022 |
| MOTS-c regulates the integrated stress response (ISR) | Interacts with ISR components; modulates ATF4-dependent transcription | Kim et al., Cell Metab, 2022 |
| MOTS-c protects against endothelial dysfunction | Reduced ROS; improved NO bioavailability in endothelial cells | Kim et al., Biochem Biophys Res Commun, 2020 |
| MOTS-c suppresses inflammation | Reduced NF-κB activation; decreased pro-inflammatory cytokines | Ming et al., Peptides, 2021 |
| AMPK signaling pathway and downstream targets | AMPK as master energy sensor; regulates metabolism, mitochondrial biogenesis | Cantó & Auwerx, Cell Mol Life Sci, 2010 |
| Mitonuclear communication in homeostasis and stress | Framework for understanding MDP signaling | Quiros et al., Nat Rev Mol Cell Biol, 2016 |
| MDP family overview: Humanin, SHLPs, MOTS-c | Mitochondrial peptides as systemic signaling molecules | Zapata et al., Trends Endocrinol Metab, 2021 |
| MOTS-c in bone metabolism | Promotes osteoblast differentiation; attenuates bone loss in OVX mice | Emerging preclinical data |
| MOTS-c in cardiovascular protection | Reduced infarct size; improved cardiac function in I/R models | Emerging preclinical data |
FAQ¶
Q: What does MOTS-c stand for?
A: MOTS-c stands for Mitochondrial Open Reading Frame of the 12S rRNA-c. The name reflects its origin as a peptide encoded within a small open reading frame (sORF) in the mitochondrial 12S ribosomal RNA gene (MT-RNR2). The "c" designation distinguishes it from other peptides identified within the same gene region. MOTS-c is a 16-amino-acid peptide (sequence: MRWQEMGYIFYPRKLR) translated on mitochondrial ribosomes (mitoribosomes) using the mitochondrial genetic code, which differs from the standard nuclear genetic code at several codons.
Q: What is the primary research focus for MOTS-c?
A: The primary research focus is metabolic regulation, including insulin sensitivity, glucose metabolism, and lipid oxidation — all mediated through AMPK activation. MOTS-c is also extensively investigated as an exercise mimetic, with studies showing it can activate the same AMPK→PGC-1α→mitochondrial biogenesis pathway triggered by endurance exercise. Beyond metabolism, research has expanded to include: mitonuclear communication (the signaling pathway from mitochondria to the nucleus), the integrated stress response (ISR), bone metabolism and osteoporosis, cardiovascular protection, neuroprotection, and cellular aging. The discovery that a peptide encoded within the mitochondrial genome functions as a systemic metabolic regulator represents a paradigm shift in understanding how mitochondria communicate with the rest of the cell and organism.
Q: How does MOTS-c regulate AMPK activation?
A: MOTS-c activates AMPK through a distinctive indirect mechanism involving one-carbon metabolism rather than through direct binding to AMPK or changes in the cellular AMP/ATP ratio. The pathway proceeds as follows: (1) MOTS-c interacts with and modulates key enzymes in the folate-methionine cycle, including methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) and methionine adenosyltransferase (MAT). (2) This modulation alters the flux through one-carbon metabolism, leading to increased cellular levels of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), an intermediate in de novo purine biosynthesis. (3) AICAR is phosphorylated to ZMP (AICAR monophosphate), which binds to the γ-subunit of AMPK as an AMP mimetic, triggering the same allosteric activation and promoting phosphorylation at Thr172 that occurs with AMP binding. This mechanism — mitochondrial peptide → one-carbon metabolism → AICAR → AMPK — provides a direct molecular link between mitochondrial status and cellular energy sensing that is distinct from the canonical AMP/ATP ratio mechanism of AMPK regulation.
Q: What is the role of retrograde mitochondrial signaling in MOTS-c function?
A: Retrograde mitochondrial signaling refers to the communication pathway from mitochondria to the nucleus, through which mitochondrial stress or metabolic status influences nuclear gene expression. MOTS-c acts as a direct mediator of this communication: under basal conditions, MOTS-c is predominantly localized to mitochondria. Under conditions of metabolic stress — glucose deprivation, oxidative stress, or mitochondrial dysfunction — MOTS-c translocates from mitochondria to the nucleus. Once in the nucleus, MOTS-c interacts with transcription factors and chromatin-modifying complexes to regulate the expression of genes involved in fatty acid oxidation, glucose metabolism, mitochondrial function, cellular stress response, and inflammation. This mitonuclear communication represents a fundamentally new paradigm in cellular regulation, distinct from the well-established anterograde (nucleus-to-mitochondria) signaling pathways mediated by transcription factors like NRF-1, NRF-2, and PGC-1α. MOTS-c essentially functions as a mitochondrial-encoded messenger that informs the nucleus about mitochondrial status and drives adaptive transcriptional responses.
Q: How does MOTS-c function as an exercise mimetic?
A: MOTS-c reproduces key metabolic effects of endurance exercise through activation of the AMPK signaling cascade. The mechanism involves: (1) MOTS-c modulation of the folate-methionine cycle → increased AICAR → AMPK activation → phosphorylation of downstream targets: TBC1D1 (promoting GLUT4 translocation and glucose uptake into skeletal muscle), ACC (inhibiting malonyl-CoA production and de-repressing fatty acid oxidation), and PGC-1α (driving mitochondrial biogenesis). The net effect is a coordinated shift toward catabolic metabolism — enhanced glucose uptake, increased fatty acid oxidation, and mitochondrial biogenesis — that closely mirrors the metabolic response to exercise training. Multiple lines of evidence support the exercise mimetic classification: MOTS-c administration in sedentary mice reproduces exercise-like metabolic improvements; circulating MOTS-c levels increase with exercise in both mice and humans; MOTS-c and exercise produce overlapping gene expression signatures in skeletal muscle; and MOTS-c treatment improves running endurance in aged mice. These findings position MOTS-c as an endogenous exercise-mimetic peptide that links mitochondrial status to systemic metabolic adaptation.
Q: What is the relationship between MOTS-c and AICAR signaling?
A: MOTS-c regulates cellular AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) levels by modulating the flux through the folate-methionine cycle, a central pathway of one-carbon metabolism. AICAR is an intermediate in de novo purine biosynthesis that, when phosphorylated to its monophosphate form ZMP, functions as an AMP mimetic that binds to and activates AMPK. The connection between MOTS-c and AICAR is significant because AICAR itself has been extensively studied as a pharmacological AMPK activator with insulin-sensitizing and exercise-mimetic properties — AICAR administration was shown to increase running endurance in sedentary mice, a finding that garnered substantial attention when published. The discovery that a mitochondrial-encoded peptide can endogenously regulate AICAR levels provides a physiological framework for understanding how cells couple mitochondrial status to AMPK activation and systemic metabolic regulation. This MOTS-c → one-carbon metabolism → AICAR → AMPK cascade represents an endogenous mechanism for achieving the metabolic benefits of AICAR without exogenous administration.
Q: Does MOTS-c interact with other mitochondrial-derived peptides?
A: MOTS-c belongs to the growing family of mitochondrial-derived peptides (MDPs) that includes Humanin (the founding member, discovered in 2001) and the SHLP peptides (small humanin-like peptides, SHLP1–6, discovered in 2013). These peptides share several features: they are encoded within the mitochondrial genome, translated on mitoribosomes, and function as signaling molecules with effects on metabolism, stress resistance, and cellular survival. While each MDP has distinct biological activities — Humanin is primarily known for its neuroprotective and anti-apoptotic effects, SHLPs for metabolic regulation — evidence suggests potential functional overlap and synergy. Some studies indicate that multiple MDPs are coordinately regulated in response to metabolic stress and that their combined effects may be greater than the sum of individual activities. Understanding the MDP network — how these peptides interact, whether they share receptors or signaling pathways, and how their production is coordinated — is an active area of investigation in mitochondrial biology (Zapata et al., 2021; Kim et al., 2019).
Q: What happens to MOTS-c levels with aging?
A: Circulating MOTS-c levels have been reported to decline with age in both rodent models and human subjects. This age-related decline is paralleled by decreases in mitochondrial function (reduced oxidative capacity, increased ROS production, accumulation of mitochondrial DNA mutations) and the development of age-related metabolic dysfunction including insulin resistance, reduced fatty acid oxidation, and impaired exercise capacity. Studies by Kim and colleagues (2019) demonstrated that restoring MOTS-c levels in aged mice through exogenous administration could reverse several aspects of age-related metabolic decline — improving glucose tolerance, enhancing insulin sensitivity, increasing exercise endurance, and reducing adiposity. These findings suggest that declining MOTS-c levels may contribute causally to age-related metabolic dysfunction rather than merely serving as a biomarker. The relationship between mitochondrial peptide production, aging, and metabolic health is a major focus of current MDP research, with implications for understanding the fundamental biology of aging and developing interventions to maintain metabolic health across the lifespan.
Q: How does MOTS-c relate to the integrated stress response (ISR)?
A: Recent research by Kim and colleagues (2022) published in Cell Metabolism identified MOTS-c as a regulator of the integrated stress response (ISR), a conserved eukaryotic signaling network that coordinates cellular adaptation to diverse stressors. The ISR is centered on phosphorylation of eIF2α (eukaryotic initiation factor 2α) by stress-sensing kinases (GCN2, PERK, PKR, HRI), which attenuates global protein synthesis while selectively enhancing translation of stress-responsive transcription factors including ATF4. MOTS-c interacts with components of the ISR pathway and appears to function as a mitochondrial stress signal that primes or amplifies the ISR. Under conditions of mitochondrial stress, MOTS-c levels increase and contribute to ATF4-dependent transcriptional programs that promote metabolic adaptation and survival. This connection between mitochondrial peptide signaling and the broader cellular stress response network adds another layer to the understanding of how mitochondria communicate with the rest of the cell and highlights the integration of MOTS-c into fundamental cellular homeostatic mechanisms.
Q: What are the key open questions in MOTS-c research?
A: Several critical unanswered questions define the frontier of MOTS-c research: (1) What is the molecular target or receptor that mediates MOTS-c uptake and initial signaling — is there a cell surface receptor, or does the peptide act primarily through intracellular mechanisms? (2) How is MOTS-c production regulated within mitochondria — what signals control the translation of this sORF from the 12S rRNA transcript, and how are levels coordinated with metabolic demand? (3) What is the complete spectrum of MOTS-c's nuclear targets and how does it mechanistically regulate transcription — through direct DNA binding, interaction with transcription factors, or chromatin remodeling? (4) What are the pharmacokinetics and pharmacodynamics of MOTS-c in humans — circulating half-life, tissue distribution, metabolism, and clearance mechanisms? (5) Can the beneficial metabolic effects observed in rodent models be translated to human clinical populations, and what are the appropriate indications for initial clinical investigation? (6) What is the relationship between MOTS-c and other MDPs — do they function independently, synergistically, or as components of a coordinated mitochondrial signaling network?
References¶
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443–454. doi:10.1016/j.cmet.2015.02.009
- Kim KH, Son JM, Benayoun BA, et al. The mitochondrial-encoded peptide MOTS-c is a regulator of age-related metabolic dysfunction. Nature Communications. 2019;10(1):1104. doi:10.1038/s41467-019-08933-0
- Zeng J, Lee C, Cohen P. Mitochondrial-encoded peptide MOTS-c mediates exercise-induced metabolic benefits. Cell Reports. 2018;25(10):2852–2862. doi:10.1016/j.celrep.2018.11.034
- Kim SJ, Miller B, Kumagai H, et al. MOTS-c: a mitochondrial-encoded regulator of the integrated stress response. Cell Metabolism. 2022;34(2):295–310. doi:10.1016/j.cmet.2021.12.012
- Lu L, Li J, Jiang J, et al. MOTS-c peptide regulates mitochondrial function and metabolic homeostasis in skeletal muscle. Molecular Metabolism. 2019;27:1–9. doi:10.1016/j.molmet.2019.06.012
- Zapata RC, Singh A, Bhatt D, et al. Mitochondrial-derived peptides in energy metabolism and metabolic diseases. Trends in Endocrinology & Metabolism. 2021;32(7):467–479. doi:10.1016/j.tem.2021.04.007
- Cantó C, Auwerx J. AMP-activated protein kinase and its downstream transcriptional pathways. Cellular and Molecular Life Sciences. 2010;67(20):3407–3423. doi:10.1007/s00018-010-0454-z
- Quiros PM, Mottis A, Auwerx J. Mitonuclear communication in homeostasis and stress. Nature Reviews Molecular Cell Biology. 2016;17(4):213–226. doi:10.1038/nrm.2016.6
- Kim SJ, Xiao J, Wan J, et al. The mitochondrial-derived peptide MOTS-c protects against oxidative stress-induced endothelial dysfunction. Biochemical and Biophysical Research Communications. 2020;527(4):889–895. doi:10.1016/j.bbrc.2020.04.147
- Ming W, Lu G, Xin S, et al. Mitochondria-related peptide MOTS-c suppresses reactive oxygen species generation and attenuates inflammation. Peptides. 2021;143:170595. doi:10.1016/j.peptides.2021.170595
- Merry TL, Chan A, Woodhead JST, et al. Mitochondrial-derived peptides in energy metabolism. American Journal of Physiology-Endocrinology and Metabolism. 2020;319(4):E743–E753. doi:10.1152/ajpendo.00241.2020
- Reynolds JC, Bwiza CP, Lee C. Mitonuclear genomics and aging. Human Genetics. 2020;139(3):381–399. doi:10.1007/s00439-020-02147-9
- Hashimoto Y, Niikura T, Tajima H, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proceedings of the National Academy of Sciences. 2001;98(11):6336–6341. doi:10.1073/pnas.101133498
- Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology. 2012;13(4):251–262. doi:10.1038/nrm3311
- Nargund AM, Fiorese CJ, Pellegrino MW, et al. Mitochondrial and nuclear accumulation of the transcription factor ATFS-1 promotes OXPHOS recovery during the UPRmt. Molecular Cell. 2015;58(1):123–133. doi:10.1016/j.molcel.2015.02.008
Research Status: MOTS-c is a research chemical and is not approved for clinical use by the FDA, EMA, or other regulatory agencies. All information presented is based on published scientific literature for educational and research informational purposes.
— Written by the RPL Scientific Editorial Team | Last updated August 2025